{
    "organizations": [],
    "uuid": "afee79b223c9e88b653ec149ac3adab3a1e1d8e0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-reata-pharmaceuticals-announces-ne/brief-reata-pharmaceuticals-announces-new-preclinical-data-of-omaveloxolone-idUSFWN1S11BO",
    "ord_in_thread": 0,
    "title": "BRIEF-Reata Pharmaceuticals Announces New Preclinical Data Of Omaveloxolone",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Reata Pharmaceuticals Inc:\n* REATA ANNOUNCES NEW PRECLINICAL DATA DEMONSTRATING THE POTENTIAL OF OMAVELOXOLONE IN THE TREATMENT OF FRIEDREICHâ€™S ATAXIA AND OTHER SEVERE NEUROLOGICAL DISEASES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T00:16:00.000+03:00",
    "crawled": "2018-04-25T00:25:28.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "reata",
        "pharmaceutical",
        "inc",
        "reata",
        "announces",
        "new",
        "preclinical",
        "data",
        "demonstrating",
        "potential",
        "omaveloxolone",
        "treatment",
        "friedreich",
        "ataxia",
        "severe",
        "neurological",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}